TAAT ™ is now sold at tobacco retailers across Great


LAS VEGAS and VANCOUVER, British Columbia, December 17, 2021 (GLOBE NEWSWIRE) – TAATâ„¢ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that TAAT â„¢ is now sold at tobacco retailers in the Greater London area of ​​the UK, primarily in the Borough of Croydon. In one May 20, 2021 press release, the company described the unique competitive advantages it could gain by selling TAAT â„¢ in the UK to include a lower price, as well as its exemption from UK federal laws which require ‘plain packaging’ of tobacco products (that is to say, TAAT â„¢ may be sold in colorful, branded packaging). Additionally, TAAT â„¢ may later capitalize on an impending market gap in the UK tobacco category after cigarette giant Philip Morris International announced in July 2021 that it plans to halt cigarette sales. tobacco in the country by the end of the decade.1.

In October 2021, the first commercial shipment of TAAT â„¢ arrived in the UK, as a partial fulfillment of over CAD $ 1,200,000 of purchase orders from Green Global Earth (“GGE”), the exclusive distributor of the company for TAAT â„¢ in the UK. . GGE leveraged TAAT’s unique value propositions to place all three varieties in at least 17 confirmed outlets across Greater London, pending reports of additional verified retail placements. GGE also obtained a Confirmation of registration from the National Health Service (“NHS”) for each specific variety of TAAT â„¢, following initial general confirmation of registration issued by Public Health England in August 2021.

Retailers in the London area who currently sell TAAT â„¢ enjoy a much greater degree of flexibility in how the product is positioned at the point of sale in order to capture the interest of smokers. legal age in store, relative to products that contain tobacco. Additionally, as menthol tobacco cigarettes were made illegal in the UK in May 20202, tobacco retailers that offer TAAT â„¢ are now able to offer their customers over the age of majority smokers the opportunity to enjoy a substantially similar smoking experience with a minty taste.

TAAT ™ CEO Setti Coscarella said: “We have launched TAAT ™ across the US over the past year and are delighted to have our first international launch in the Greater London area. Similar to what we did in Ohio last December, we are focusing on specific areas of Greater London, such as Croydon, where GGE believes there are strategic advantages to launching TAAT ™ ahead of us. expand into other parts of the UK. Something that you will notice in many convenience stores and other tobacco retailers in the UK is that it is very common for them to advertise various products which impart a menthol taste and smell to cigarettes. ordinary, as menthol tobacco cigarettes can no longer be sold in the UK. This is one aspect of the UK market around which we are building our go-to-market strategy, as we continue to execute our first TAAT ™ launch outside of the US.

Sources

1 – https://www.npr.org/2021/07/26/1020571339/marlboro-maker-ceo-says-the-company-plans-to-stop-selling-smokes-in-the-uk

2 – https://www.acs.org.uk/advice/menthol-ban

On behalf of the Board of Directors of the Company,

TAATâ„¢ WORLDWIDE ALTERNATIVES INC.

“Setti Coscarella”

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT â„¢ Investor Relations
1-833-TAAT-United States (1-833-822-8872)
[email protected]

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS COMMUNICATION, NOR THE CSE REGULATORY SERVICE PROVIDER.

About TAATâ„¢ Global Alternatives Inc.

The Company has developed TAAT â„¢, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in the “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT â„¢ is Beyond Tobacco â„¢, a proprietary blend that undergoes a patent pending refinement technique that makes its scent and taste resemble tobacco. Under the leadership of management with the “Big Tobacco” pedigree, TAAT â„¢ was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself in the $ 814 billion mark.1 the global tobacco industry.

For more information, please visit http://taatglobal.com.

The references

1 British American Tobacco – The Global Market

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “believes” , “Intention”, “” anticipates “or” does not anticipate “, or” believes “, or variations of these words and expressions or declares that certain actions, events or results” could “,” could “,” would “,” could “or” be “to be taken, to occur or to be achieved. Forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT â„¢ in the tobacco industry, in addition to the following : Continued performance of TAAT â„¢ at retail in stores located in the UK Forward-looking information reflects management’s current expectations based on information currently available and is subject to a number of risks and uncertainties which may cause so that e the results differ significantly from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, such information should not be relied on unduly and no assurance can be given that such events will occur within the time limits disclosed or in the future. all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , unless required by applicable law.

The statements contained in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. Because everyone is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or guarantee can be made as to the effects of the Company’s products on the health and well-being of an individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third party entities (or their respective offerings with brand names) generally in reference to (i) relationships between the Company and third party entities mentioned in this release and / or (ii) the client / supplier / service provider parties whose relationship with the Company is / are mentioned in this press release. All rights to these trademarks are reserved by their respective owners or licensees.

Statement Regarding Third Party Investor Relations Firms

Information relating to investor relations companies retained by TAAT â„¢ Global Alternatives Inc. can be viewed under the company profile at http://sedar.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/06863f5a-006e-4f80-bb3e-4e29a6930c12

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …